| Literature DB >> 33617951 |
Oladayo A Afolabi1, Mary Abboah-Offei2, Eve Namisango3, Emeka Chukwusa2, Adejoke O Oluyase2, Emmanuel B K Luyirika4, Richard Harding2, Kennedy Nkhoma2.
Abstract
CONTEXT: Palliative care should be a component of COVID-19 management to relieve suffering, improve patient outcomes and save cost.Entities:
Keywords: COVID-19; Palliative care; clinical guideline
Year: 2021 PMID: 33617951 PMCID: PMC7894087 DOI: 10.1016/j.jpainsymman.2021.01.126
Source DB: PubMed Journal: J Pain Symptom Manage ISSN: 0885-3924 Impact factor: 3.612
The adequacy of the Guidelines Against the APCA Standards for Quality Palliative Care in 15 Countries
| Countries | 2.1: Planning and Coordination of Care | 2.2: Access to Care | 2.3: Communication in Palliative Care | 2.4: Pain and Symptom Management | 2.5: Management of Opportunistic Infections (OIs) | 2.6: Management of Medications | 2.7: Psychosocial Care | 2.8: Spiritual Care | 2.9: Cultural Care | 2.10: Complementary Therapies in Palliative Care | 2.11: Care for Special Needs Populations | 2.12: End-of-life care | 2.13: Grief, Loss and Bereavement Care in Adults | 2.14: Ethical Care, Human Rights and Legal Support | 2.15: Clinical Supervision | 2.16: Inter-Disciplinary Team | 2.17: Providing Support to Care Providers |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| + | X | x | + | ++ | + | x | x | x | x | x | x | x | x | N/A | x | + | |
| + | + | x | + | ++ | + | x | x | x | + | + | x | x | x | N/A | x | + | |
| + | + | + | + | x | + | + | x | x | x | + | x | x | x | N/A | + | + | |
| + | + | ++ | + | ++ | + | + | + | + | x | + | + | + | + | N/A | x | + | |
| + | + | x | + | ++ | + | + | x | x | x | + | x | x | x | N/A | x | + | |
| + | X | x | + | ++ | + | x | x | x | x | x | x | x | x | N/A | x | + | |
| + | + | x | + | ++ | + | + | x | x | x | + | x | x | x | N/A | x | + | |
| + | X | x | + | ++ | + | x | x | x | + | + | x | x | x | N/A | x | + | |
| + | + | x | + | ++ | + | x | x | x | x | + | + | x | x | N/A | x | + | |
| ++ | ++ | ++ | ++ | ++ | + | ++ | + | + | + | ++ | x | x | + | N/A | ++ | + | |
| + | + | + | + | ++ | + | x | x | x | + | + | x | x | x | N/A | x | + | |
| + | X | + | + | ++ | + | + | x | + | x | + | + | x | + | N/A | x | + | |
| + | + | ++ | + | ++ | + | ++ | x | + | x | + | ++ | ++ | x | N/A | ++ | ++ | |
| + | + | x | + | ++ | + | x | x | x | + | x | x | x | x | N/A | x | + | |
| + | + | + | + | ++ | + | + | x | x | x | ++ | x | x | + | N/A | ++ | + |
++, fully met.
+, partially met.
x, not met.
N/A, not applicable.
Fig. 1.PRISMA flow chart of guideline selection.